top of page


Advantages of using WHO Drug ATC Classification for Disproportionality Analysis
WHO Drug Anatomical Therapeutic Chemical (ATC) Classification organizes drugs into 14 major groups. These groups are further...
Senthil Selvaraj
Sep 19, 20231 min read
14 views


Biktarvy - Weight increased potential signal
FDA 2023 Q1 potential signals include Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) - Weight increased as a potential...
Senthil Selvaraj
Jul 6, 20231 min read
18 views
0 comments


PD-1/PDL-1 inhibitors - Keratoacanthoma potential signal
PD-1/PDL-1 inhibitors potential signal
Senthil Selvaraj
May 9, 20231 min read
4 views
0 comments


Ocrevus (ocrelizumab) - Progressive multifocal leukoencephalopathy potential signal
As of Dec 2022, 27 Progressive multifocal leukoencephalopathy reports were in the FAERS database for Ocrelizumab. The PRRs are below 2...
Senthil Selvaraj
May 9, 20231 min read
6 views
0 comments


HMG-CoA reductase inhibitors - DRESS potential signal
Posted potential safety issue As of Dec 2022, there were a few HMG-CoA reductase inhibitors with DRESS adverse event PRR > 2. Some of the...
Senthil Selvaraj
May 4, 20231 min read
12 views
0 comments


Addyi (flibanserin) - Accidental exposure to product by child potential signal
As of Dec 2022, 20 Accidental exposure to product by child reports were in the FAERS database for Flibanserin. The PRRs are above 2 for...
Senthil Selvaraj
May 4, 20231 min read
5 views
0 comments


Disproportionality Analysis
An easy way to analyze your drug for potential signals
Senthil Selvaraj
May 3, 20232 min read
27 views
0 comments
bottom of page